Showing results (1151-1160 of 2,491) with videos related to
Sort By:
Pageof 250
Expert Review of Vaccines|June 6, 2018
Causality assessment of serious and severe adverse events following immunization in India: a 4-year practical experienceAwnish K Singh, Abram L Wagner, Jyoti Joshi, et al.Expert Review of Vaccines|February 17, 2015
An overview of tuberculosis plant-derived vaccinesSergio Rosales-Mendoza, Regina Ríos-Huerta, Carlos AnguloExpert Review of Vaccines|June 18, 2014
Human type 5 adenovirus-based tuberculosis vaccine: is the respiratory route of delivery the future?Fiona Smaill, Zhou XingExpert Review of Vaccines|February 4, 2015
Immunology and vaccines and nanovaccines for Helicobacter pylori infectionMorteza Milani, Yaeghob Sharifi, Mohammad Rahmati-Yamchi, et al.Expert Review of Vaccines|July 2, 2020
A systematic review of vaccine availability at the national, district, and health facility level in the WHO African RegionChinwe Juliana Iwu, Ntombehle Ngcobo, Anelisa Jaca, et al.Expert Review of Vaccines|February 13, 2023
Research progress on substitution of in vivo method(s) by in vitro method(s) for human vaccine potency assaysXuanxuan Zhang, Xing Wu, Qian He, et al.Expert Review of Vaccines|February 22, 2023
Digital health technology used in emergency large-scale vaccination campaigns in low- and middle-income countries: a narrative review for improved pandemic preparednessPaula Mc Kenna, Lindsay A Broadfield, Annik Willems, et al.Expert Review of Vaccines|June 27, 2015
Protective efficacy of two novel DNA vaccines expressing Toxoplasma gondii rhomboid 4 and rhomboid 5 proteins against acute and chronic toxoplasmosis in miceNian-Zhang Zhang, Ying Xu, Meng Wang, et al.Expert Review of Vaccines|August 15, 2022
Duration of immunogenicity of high-dose and prolonged-schedule hepatitis B vaccine among patients with chronic kidney disease: A one year follow-up study in ChinaYujie Han, Na Cao, Xiaoxiao Lu, et al.Expert Review of Vaccines|August 25, 2022
Chlamydia trachomatis vaccine development - a view on the current challenges and how to move forwardÁlvaro H Borges, Frank Follmann, Jes DietrichPageof 250